In patients with intermediate-low risk pulmonary embolism: cardiac enzyme or right ventricle dysfunction or sPESI

F. Öztuna (Trabzon, Turkey)

Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Session: Prognostic factors and outcomes in pulmonary embolism
Session type: Poster Discussion
Number: 559
Disease area: Pulmonary vascular diseases, Respiratory critical care

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Öztuna (Trabzon, Turkey). In patients with intermediate-low risk pulmonary embolism: cardiac enzyme or right ventricle dysfunction or sPESI. 559

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prediction of right ventricular dysfunction in patients with pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 602s
Year: 2007

Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017


Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism
Source: Eur Respir J, 50 (6) 1701611; 10.1183/13993003.01611-2017
Year: 2017



Digoxin effect in mortality associated to right ventricular dysfunction in patients with pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019

The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001

Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006

Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019


Prognostic significance of right ventricular dysfunction detected by CT/Echocardiography and biomarkers in normotensive patients with pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010


Pulmonary hypertension and right ventricular impairment in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Prevalence of pulmonary hypertension and right ventricular dysfunction in patients with mixed types of ILD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Right heart dysfunction (RHD) in patients with acute pulmonary embolism (PE): correlation between distribution of clots, troponin I and prognosis
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi
Source: Eur Respir J, 56 (5) 2000538; 10.1183/13993003.00538-2020
Year: 2020



Evaluation of right atrium remodeling in patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2010 - State of the art imaging
Year: 2010

Pulmonary hypertension and right ventricular impairment in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004

Agreement of right ventricular enlargement assessed by CT angiogram for risk stratifying normotense patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Pulmonary embolism and the consequences for the right heart
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136
Year: 2006

Always think of the right ventricle, even in “low-risk” pulmonary embolism
Source: Eur Respir J, 50 (6) 1702386; 10.1183/13993003.02386-2017
Year: 2017



Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 26s
Year: 2002